New and emerging therapies for hemophilia are transforming clinical pathways in patient care. Such therapies include extended half-life products, non-factor/rebalancing therapies, and even gene therapies. But while this expanding armamentarium is a triumph in the evolution of hemophilia prophylaxis and treatment, patient access to such breakthroughs remains limited, especially in underserved populations. In this 30-minute CME Outfitters Snack activity, two experts in hemophilia explore the reasons behind inequities in care. Indeed, non-White patients with hemophilia have the highest rates of mortality, chronic pain, impaired functional status, and hemophilia-related distress. Beyond illuminating the scope of the problem, the faculty provides several actionable strategies to help practicing clinicians ensure equitable care for all patients.
- Provider:CME Outfitters, LLC
- Activity Link: https://www.cmeoutfitters.com/activity/racial-and-ethnic-disparities-in-the-context-of-new-and-emerging-treatments-for-hemophilia/
- Start Date: 2024-07-24 05:00:00
- End Date: 2024-07-24 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine